1. Home
  2. SILO vs KAVL Comparison

SILO vs KAVL Comparison

Compare SILO & KAVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SILO
  • KAVL
  • Stock Information
  • Founded
  • SILO 2010
  • KAVL 1998
  • Country
  • SILO United States
  • KAVL United States
  • Employees
  • SILO N/A
  • KAVL N/A
  • Industry
  • SILO Apparel
  • KAVL Medicinal Chemicals and Botanical Products
  • Sector
  • SILO Consumer Discretionary
  • KAVL Health Care
  • Exchange
  • SILO Nasdaq
  • KAVL Nasdaq
  • Market Cap
  • SILO 8.8M
  • KAVL 8.9M
  • IPO Year
  • SILO N/A
  • KAVL N/A
  • Fundamental
  • Price
  • SILO $1.78
  • KAVL $1.36
  • Analyst Decision
  • SILO
  • KAVL
  • Analyst Count
  • SILO 0
  • KAVL 0
  • Target Price
  • SILO N/A
  • KAVL N/A
  • AVG Volume (30 Days)
  • SILO 9.1M
  • KAVL 1.2M
  • Earning Date
  • SILO 02-14-2025
  • KAVL 03-24-2025
  • Dividend Yield
  • SILO N/A
  • KAVL N/A
  • EPS Growth
  • SILO N/A
  • KAVL N/A
  • EPS
  • SILO N/A
  • KAVL N/A
  • Revenue
  • SILO $72,102.00
  • KAVL $10,108,906.00
  • Revenue This Year
  • SILO $1.86
  • KAVL $652.90
  • Revenue Next Year
  • SILO N/A
  • KAVL N/A
  • P/E Ratio
  • SILO N/A
  • KAVL N/A
  • Revenue Growth
  • SILO N/A
  • KAVL N/A
  • 52 Week Low
  • SILO $0.77
  • KAVL $0.58
  • 52 Week High
  • SILO $4.50
  • KAVL $9.69
  • Technical
  • Relative Strength Index (RSI)
  • SILO 57.77
  • KAVL 61.11
  • Support Level
  • SILO $1.56
  • KAVL $1.13
  • Resistance Level
  • SILO $1.89
  • KAVL $1.45
  • Average True Range (ATR)
  • SILO 0.19
  • KAVL 0.18
  • MACD
  • SILO -0.04
  • KAVL 0.01
  • Stochastic Oscillator
  • SILO 47.46
  • KAVL 77.35

About SILO Silo Pharma Inc.

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.

About KAVL Kaival Brands Innovations Group Inc.

Kaival Brands Innovations Group Inc is focused on growing and incubating innovative and profitable products. The company is engaged in the sale, marketing and distribution of electronic nicotine delivery system (ENDS) products and related components. Its primary product includes Bidi Stick. The BIDI Stick comes in a variety of flavor options for adult cigarette smokers.

Share on Social Networks: